Imaging with [(89)Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: a phase 1/2, first-in-human trial
使用[(89)Zr]Zr-DFO-SC16.56抗DLL3抗体对肺癌和前列腺高级别神经内分泌肿瘤患者进行成像:一项1/2期首次人体试验
期刊:Lancet Oncology
影响因子:35.9
doi:10.1016/S1470-2045(24)00249-3
Tendler, Salomon; Dunphy, Mark P; Agee, Matthew; O'Donoghue, Joseph; Aly, Rania G; Choudhury, Noura J; Kesner, Adam; Kirov, Assen; Mauguen, Audrey; Baine, Marina K; Schoder, Heiko; Weber, Wolfgang A; Rekhtman, Natasha; Lyashchenko, Serge K; Bodei, Lisa; Morris, Michael J; Lewis, Jason S; Rudin, Charles M; Poirier, John T